Related Experiment Videos
[Dyslipidemia: a predisposing or etiologic factor in atherosclerosis]
1Service de médecine vasculaire, hôpital Broussais, Paris.
Insights
Hypercholesterolemia is a significant risk factor for atherosclerosis, though not its sole cause. Treating elevated cholesterol, even mildly, offers proven cardiovascular benefits in high-risk individuals.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Epidemiology
Context:
- Atherosclerosis is a major cardiovascular disease.
- Hypercholesterolemia is a well-established risk factor.
- The causal role of cholesterol in atherosclerosis is debated.
Purpose:
- To review the established link between hypercholesterolemia and atherosclerosis.
- To discuss the implications of cholesterol not being an obligatory factor in atherosclerosis.
- To highlight the therapeutic benefits of treating hypercholesterolemia.
Summary:
- Epidemiological and experimental data strongly link hypercholesterolemia to atherosclerosis.
- While not strictly causal, elevated cholesterol is a major risk factor.
- Randomized trials confirm the benefits of treating hypercholesterolemia for cardiovascular prevention.
Impact:
- Treatment of hypercholesterolemia provides a valuable therapeutic strategy.
- These findings reinforce the importance of managing cholesterol levels.
- This knowledge expands the cardiological treatment options for patients.
Abstract:
Epidemiological and experimental data linking hypercholesterolaemia to atherosclerosis is well established and confirms it has a major risk factor for atherosclerosis. The fact that an increase in blood cholesterol is not necessary or obligatory for atherosclerosis to occur, means that it cannot be considered as a causal factor of the disease. On the other hand, the benefits of treatment of hypercholesterolaemia, even in mildly elevated concentrations, have been demonstrated in many randomised trials of primary and secondary prevention in high risk subjects. Thus, beyond the arguments over cholesterol being a predisposing or causal factor, these universally accepted results have added a new therapeutic arm to the cardiological arsenal.